BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29577611)

  • 1. SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies.
    Naderi A
    Mol Oncol; 2018 May; 12(5):724-755. PubMed ID: 29577611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
    Naderi A
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of the tumor suppressor HSPB7, involved in the p53 pathway, in renal cell carcinoma by hypermethylation.
    Lin J; Deng Z; Tanikawa C; Shuin T; Miki T; Matsuda K; Nakamura Y
    Int J Oncol; 2014 May; 44(5):1490-8. PubMed ID: 24585183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.
    Naderi A
    Chromosome Res; 2020 Dec; 28(3-4):307-330. PubMed ID: 32816122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.
    Mestre-Escorihuela C; Rubio-Moscardo F; Richter JA; Siebert R; Climent J; Fresquet V; Beltran E; Agirre X; Marugan I; Marín M; Rosenwald A; Sugimoto KJ; Wheat LM; Karran EL; García JF; Sanchez L; Prosper F; Staudt LM; Pinkel D; Dyer MJ; Martinez-Climent JA
    Blood; 2007 Jan; 109(1):271-80. PubMed ID: 16960149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer.
    Chien J; Staub J; Avula R; Zhang H; Liu W; Hartmann LC; Kaufmann SH; Smith DI; Shridhar V
    Oncogene; 2005 Jul; 24(32):5089-100. PubMed ID: 15870691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of steroid receptor-associated and regulated protein in tumor progression and progesterone receptor signaling in endometrial cancer.
    Liu J; Wang Z; Zhou J; Wang J; He X; Wang J
    Chin Med J (Engl); 2023 Nov; 136(21):2576-2586. PubMed ID: 37144734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-Vascular Heat Shock Protein (cvHsp, HspB7), an Unusual Representative of Small Heat Shock Protein Family.
    Muranova LK; Shatov VM; Bukach OV; Gusev NB
    Biochemistry (Mosc); 2021 Jan; 86(Suppl 1):S1-S11. PubMed ID: 33827396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones.
    Vos MJ; Zijlstra MP; Kanon B; van Waarde-Verhagen MA; Brunt ER; Oosterveld-Hut HM; Carra S; Sibon OC; Kampinga HH
    Hum Mol Genet; 2010 Dec; 19(23):4677-93. PubMed ID: 20843828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
    Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
    Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
    Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity.
    Araki D; Uzawa K; Watanabe T; Shiiba M; Miyakawa A; Yokoe H; Tanzawa H
    Int J Oncol; 2002 Feb; 20(2):355-60. PubMed ID: 11788901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
    van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
    J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
    Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
    Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
    Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
    Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1p36 tumor suppression--a matter of dosage?
    Henrich KO; Schwab M; Westermann F
    Cancer Res; 2012 Dec; 72(23):6079-88. PubMed ID: 23172308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.
    Lando M; Fjeldbo CS; Wilting SM; C Snoek B; Aarnes EK; Forsberg MF; Kristensen GB; Steenbergen RD; Lyng H
    Epigenetics; 2015; 10(10):970-80. PubMed ID: 26291246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.